Page last updated: 2024-09-03

cimadronate and Body Weight

cimadronate has been researched along with Body Weight in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (83.33)18.2507
2000's1 (16.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, T; Kanoh, H; Kawashima, H; Motoie, H; Nakamura, T; Nishikawa, H; O'uchi, N1
Endo, N; Mashiba, T; Nishida, S; Takahashi, HE; Takano, Y; Tanizawa, T1
Fujikura, T; Kanoh, H; Motoie, H; Okazaki, A; Shikama, H1
Kaji, Y; Kawanishi, J; Komatsubara, S; Li, J; Mashiba, T; Mori, S; Norimatsu, H; Taki, M1
Kikuchi, T; Kudo, H; Mitamura, T; Sakamoto, S; Sassa, S; Shinoda, H; Suzuki, S; Yoshimura, S; Zhou, Y1
Akiyama, T; Kaji, Y; Kawanishi, J; Li, J; Mori, S; Norimatsu, H1

Other Studies

6 other study(ies) available for cimadronate and Body Weight

ArticleYear
Effects of the bisphosphonate YM175 on bone mineral density, strength, structure, and turnover in ovariectomized beagles on concomitant dietary calcium restriction.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1995, Volume: 10, Issue:6

    Topics: Administration, Oral; Alkaline Phosphatase; Analysis of Variance; Animals; Biomechanical Phenomena; Body Weight; Bone Density; Bone Development; Bone Resorption; Calcium; Dihydroxycholecalciferols; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Female; Femur; Femur Neck; Humans; Lumbar Vertebrae; Osteoporosis, Postmenopausal; Ovariectomy; Random Allocation; Regression Analysis

1995
Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1996, Volume: 11, Issue:2

    Topics: Animals; Body Weight; Bone Density; Bone Development; Diphosphonates; Drug Administration Schedule; Drug Therapy, Combination; Female; Femur; Humans; Ovariectomy; Ovary; Rats; Rats, Sprague-Dawley; Teriparatide; Tibia

1996
Increase of bone mass and mechanical strength in rats after treatment with a novel bisphosphonate, YM175, for two years.
    Pharmacology & toxicology, 1997, Volume: 81, Issue:1

    Topics: Animals; Body Weight; Bone and Bones; Diphosphonates; Female; Humerus; Male; Mortality; Rats; Rats, Inbred F344

1997
Preadministration of incadronate disodium can prevent bone loss in rat proximal tibial metaphysis when induced by hindlimb immobilization by bandage.
    Bone, 1998, Volume: 23, Issue:5

    Topics: Animals; Body Weight; Bone Diseases, Metabolic; Diphosphonates; Disease Models, Animal; Female; Hindlimb; Image Processing, Computer-Assisted; Immobilization; Rats; Rats, Sprague-Dawley; Tibia

1998
Prevention of osteopenia induced with a gonadotropin-releasing hormone agonist in rats.
    Calcified tissue international, 1999, Volume: 65, Issue:2

    Topics: Animals; Body Weight; Bone Density; Bone Diseases, Metabolic; Diphosphonates; Estradiol; Estrogens, Conjugated (USP); Female; Femur; Fertility Agents, Female; Follicle Stimulating Hormone; Hydroxycholecalciferols; Leuprolide; Luteinizing Hormone; Organ Size; Ovariectomy; Radiography; Rats; Rats, Sprague-Dawley

1999
Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2000, Volume: 15, Issue:10

    Topics: Animals; Apoptosis; Body Weight; Bony Callus; Cell Count; Diphosphonates; Female; Femoral Fractures; Histocytochemistry; In Situ Hybridization; Osteoclasts; Radiography; Rats; Rats, Sprague-Dawley; Wound Healing

2000